CA90578/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2004	3
2005	8
2006	7
2007	4
2008	4
2009	3
2010	3
2011	2
2012	3
2013	2
2014	3
2015	1
2024	0

1

Cyclin-dependent kinase pathways as targets for cancer treatment.

Shapiro GI. Shapiro GI. J Clin Oncol. 2006 Apr 10;24(11):1770-83. doi: 10.1200/JCO.2005.03.7689. J Clin Oncol. 2006. PMID: 16603719 Review.

2

Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol.

Shapiro GI. Shapiro GI. Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4270s-4275s. doi: 10.1158/1078-0432.CCR-040020. Clin Cancer Res. 2004. PMID: 15217973 Review.

3

Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk.

Su L, Zhou W, Park S, Wain JC, Lynch TJ, Liu G, Christiani DC. Su L, et al. Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):567-70. doi: 10.1158/1055-9965.EPI-04-0482. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15767330

4

Dietary iron, zinc, and calcium and the risk of lung cancer.

Zhou W, Park S, Liu G, Miller DP, Wang LI, Pothier L, Wain JC, Lynch TJ, Giovannucci E, Christiani DC. Zhou W, et al. Epidemiology. 2005 Nov;16(6):772-9. doi: 10.1097/01.ede.0000181311.11585.59. Epidemiology. 2005. PMID: 16222167

5

Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer.

Su L, Zhou W, Asomaning K, Lin X, Wain JC, Lynch TJ, Liu G, Christiani DC. Su L, et al. Carcinogenesis. 2006 May;27(5):1024-9. doi: 10.1093/carcin/bgi283. Epub 2005 Nov 25. Carcinogenesis. 2006. PMID: 16311244

6

Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer.

Zhou W, Liu G, Park S, Wang Z, Wain JC, Lynch TJ, Su L, Christiani DC. Zhou W, et al. Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):491-6. doi: 10.1158/1055-9965.EPI-04-0612. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15734977

7

BCL2 suppresses PARP1 function and nonapoptotic cell death.

Dutta C, Day T, Kopp N, van Bodegom D, Davids MS, Ryan J, Bird L, Kommajosyula N, Weigert O, Yoda A, Fung H, Brown JR, Shapiro GI, Letai A, Weinstock DM. Dutta C, et al. Cancer Res. 2012 Aug 15;72(16):4193-203. doi: 10.1158/0008-5472.CAN-11-4204. Epub 2012 Jun 11. Cancer Res. 2012. PMID: 22689920 Free PMC article.

8

SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas.

Watanabe H, Ma Q, Peng S, Adelmant G, Swain D, Song W, Fox C, Francis JM, Pedamallu CS, DeLuca DS, Brooks AN, Wang S, Que J, Rustgi AK, Wong KK, Ligon KL, Liu XS, Marto JA, Meyerson M, Bass AJ. Watanabe H, et al. J Clin Invest. 2014 Apr;124(4):1636-45. doi: 10.1172/JCI71545. Epub 2014 Mar 3. J Clin Invest. 2014. PMID: 24590290 Free PMC article.

9

Whole-miRNome profiling identifies prognostic serum miRNAs in esophageal adenocarcinoma: the influence of Helicobacter pylori infection status.

Zhai R, Wei Y, Su L, Liu G, Kulke MH, Wain JC, Christiani DC. Zhai R, et al. Carcinogenesis. 2015 Jan;36(1):87-93. doi: 10.1093/carcin/bgu228. Epub 2014 Nov 8. Carcinogenesis. 2015. PMID: 25381453 Free PMC article.

10

Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma.

Barletta JA, Perner S, Iafrate AJ, Yeap BY, Weir BA, Johnson LA, Johnson BE, Meyerson M, Rubin MA, Travis WD, Loda M, Chirieac LR. Barletta JA, et al. J Cell Mol Med. 2009 Aug;13(8B):1977-1986. doi: 10.1111/j.1582-4934.2008.00594.x. J Cell Mol Med. 2009. PMID: 19040416 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

38 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year